Cargando…
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
Despite advances in pharmacotherapy, intervention devices and techniques, residual cardiovascular risks still cause a large burden on public health. Whilst most guidelines encourage achieving target levels of specific lipids and lipoproteins to reduce these risks, increasing evidence has shown that...
Autores principales: | Lee, Chih-Kuo, Liao, Che-Wei, Meng, Shih-Wei, Wu, Wei-Kai, Chiang, Jiun-Yang, Wu, Ming-Shiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393881/ https://www.ncbi.nlm.nih.gov/pubmed/34440189 http://dx.doi.org/10.3390/biomedicines9080985 |
Ejemplares similares
-
Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011) -
Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023) -
Atherosclerosis Calcification: Focus on Lipoproteins
por: Neels, Jaap G., et al.
Publicado: (2023) -
Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice
por: ZHANG, BU-CHUN, et al.
Publicado: (2012) -
Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis
por: Yeh, Chih-Fan, et al.
Publicado: (2020)